NP 13 (QuilliChew ER 30 mg)
Generic Name: methylphenidate
Pill with imprint NP 13 is Pink, Capsule-shape and has been identified as QuilliChew ER 30 mg. It is supplied by Pfizer Inc..
QuilliChew ER is used in the treatment of adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. QuilliChew ER 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for NP 13
QuilliChew ER
- Generic Name:
- methylphenidate
- Imprint:
- NP 13
- Strength:
- 30 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Labeler / Supplier:
- Pfizer Inc.
- National Drug Code (NDC):
- 24478-0130
More about QuilliChew ER (methylphenidate)
- QuilliChew ER Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- Drug class: CNS stimulants
- FDA Alerts (3)
Consumer resources
Other brands: Concerta, Ritalin, Daytrana, Methylin, ... +9 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
